Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Yongjun Sui

 Yongjun Sui
 Yongjun Sui
Scientist
Molecular Immunogenetics and Vaccine
National Cancer Institute
National Institute of Health
USA

Biography

Yongjun Sui is a scientist of Vaccine Brach National Institute of Cancer National Institute of Health NIH. She received her PhD from Beijing Institute of Basic Medical Sciences 1998. After postdoctoral trainings at Kansas University Medical Center and University of Pittsburgh she joined NIH in 2008. She has over 26 scientific publications and is a reviewer for Experimental Hematology.

Research Interest

Dr. Yongjun Sui focus on studying the innate and adaptive immunological mechanisms of human immunodeficiency virus/simian immunodeficiency virus (HIV/SIV) vaccine-induced control of HIV mucosal transmission using SIV/SHIV-macaque models. In addition, she is interested in exploring new technologies and novel molecular adjuvants to help prevent mucosal HIV-1 transmission.

Top